Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV

NCT02906007 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

54

Enrollment

NIH

Sponsor class

Conditions

Tuberculosis
HIV

Interventions

DRUG: Bedaquiline

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]